Diabetes care is a complex landscape of continuous
innovation with new treatments and new devices. Each
advancement helps make a meaningful difference in the lives
of people with diabetes, yet significant unmet needs remain.
Novo Nordisk, Abbott and the diaTribe Foundation are all
committed to improving the lives of people with diabetes,
and we believe one of the most promising and important
evolutions in the management of diabetes today is about
something very simple, yet incredibly impactful. It’s about
Time in Range.
Time in Range is a new approach to managing diabetes that
can benefit both people with diabetes and their healthcare
providers. More than a parameter for evaluating glucose
levels, Time in Range uses valuable information to better
inform the management of diabetes at an individual level. It
provides actionable insights that can empower people living
with diabetes to take better control of their health and
their future. By helping us understand today, Time in Range
is our tool for creating a brighter tomorrow.
Together we are joining forces to improve the lives of
people living with diabetes by raising awareness and
understanding of the importance of Time in Range as the
emerging standard of care.